# Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome

> **NCT00711841** · PHASE4 · TERMINATED · sponsor: **Instituto Materno Infantil Prof. Fernando Figueira** · enrollment: 400 (estimated)

## Conditions studied

- HELLP Syndrome

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** Placebo
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT00711841
- **Lead sponsor:** Instituto Materno Infantil Prof. Fernando Figueira
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 400 (ESTIMATED)
- **Why stopped:** The speed of recruitment was slower than anticipated.
- **Last updated:** 2019-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711841, "Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00711841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*